Showing results (21-30 of 146) with videos related to
Sort By:
Pageof 15
Cleveland Clinic Journal of Medicine|August 24, 2004
The promise of targeted therapy: cancer drugs become more specificEna Segota, Ronald M BukowskiTherapeutics and Clinical Risk Management|September 24, 2009
Role of everolimus in the treatment of renal cell carcinomaSaby George, Ronald M BukowskiExpert Review of Anticancer Therapy|December 8, 2007
Biomarkers in clear cell renal cell carcinomaSaby George, Ronald M BukowskiCancer Investigation|September 20, 2006
Targeted therapy for renal cell carcinoma: a new therapeutic paradigmPhilip E Shaheen, Ronald M BukowskiClinical Genitourinary Cancer|January 24, 2007
Pathways of dysregulation in renal cell carcinoma: rational approaches to development of novel treatmentMohamad K Khasawneh, Ronald M BukowskiJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2006
Targeted therapy for metastatic renal cell carcinomaRobert J Motzer, Ronald M BukowskiClinical Genitourinary Cancer|May 30, 2006
Sorafenib: recent update on activity as a single agent and in combination with interferon-alpha2 in patients with advanced-stage renal cell carcinomaG Kesava Reddy, Ronald M BukowskiExpert Opinion on Investigational Drugs|September 24, 2008
Novel drugs for renal cell carcinomaBhanu K Vakkalanka, Ronald M BukowskiGenome Medicine|January 4, 2012
Predicting responses to sunitinib using single nucleotide polymorphisms: Progress and recommendations for future trialsRam N Ganapathi, Ronald M BukowskiOncology (Williston Park, N.Y.)|May 14, 2008
Targeted therapy for metastatic renal cell carcinoma: a home run or a work in progress?Brian I Rini, Ronald M BukowskiPageof 15